Avecho Biotechnology (ASX:AVE) Other Operating Expense: A$2.76 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Avecho Biotechnology Other Operating Expense?

Avecho Biotechnology ASX:AVE -4.55% Other Operating Expense is A$2.76 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Avecho Biotechnology's Other Operating Expense for the six months ended in Dec. 2025 was A$1.93 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$2.76 Mil.

Avecho Biotechnology's quarterly Other Operating Expense increased from Dec. 2024 (A$0.47 Mil) to Jun. 2025 (A$0.83 Mil) and increased from Jun. 2025 (A$0.83 Mil) to Dec. 2025 (A$1.93 Mil).

Avecho Biotechnology's annual Other Operating Expense increased from Dec. 2023 (A$0.18 Mil) to Dec. 2024 (A$1.41 Mil) and increased from Dec. 2024 (A$1.41 Mil) to Dec. 2025 (A$4.83 Mil).

Avecho Biotechnology Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Avecho Biotechnology's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avecho Biotechnology Other Operating Expense Chart

Avecho Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 0.78 0.18 1.41 4.83

Avecho Biotechnology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.23 0.94 0.47 0.83 1.93

Avecho Biotechnology Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$2.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of A$2.76 Mil mean?
Avecho Biotechnology (ASX:AVE) has a Other Operating Expense of A$2.76 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Avecho Biotechnology and its competitors.
Is Avecho Biotechnology's Other Operating Expense too high?
Avecho Biotechnology's current Other Operating Expense is A$2.76 Mil.
How does Avecho Biotechnology's Other Operating Expense compare to VRTX and REGN?
Avecho Biotechnology's Other Operating Expense of A$2.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Avecho Biotechnology and its competitors. Avecho Biotechnology's current Other Operating Expense is A$2.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (ASX:AVE) has a current Other Operating Expense of A$2.76 Mil. The current Other Operating Expense is A$2.76 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Avecho Biotechnology (ASX:AVE), the current Other Operating Expense is A$2.76 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avecho Biotechnology Business Description

Other Exchanges OEZ:Germany
Address Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.